Covid-19: Pfizer withdraws Emergency Use Authorisation application in India
Pharma
major Pfizer on Friday said it
has decided to withdraw its application for Emergency Use Authorisation (EUA)
of its COVID-19 vaccine in India.
Pfizer
was the first pharmaceutical firm to seek an emergency use authorisation from
the Drugs Controller General of India (DCGI) for its COVID-19 vaccine in the
country, after it secured such clearance in the UK and Bahrain.
"In
pursuance of the Emergency Use Authorisation of its COVID-19 vaccine, Pfizer
participated in the Subject Expert Committee meeting of the Drug Regulatory
Authority of India on February 3. Based on the deliberations at the meeting and
our understanding of additional information that the regulator may need, the
company has decided to withdraw its application at this time," a company
spokesperson said in a statement.
Pfizer
will continue to engage with the authority and resubmit its approval request
with additional information as it becomes available in the near future, the
statement said. Read More
Comments
Post a Comment